Vaginal Microbiome Exposure and Immune Responses in C-section Infants
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hugh A. Sampson, MD
Icahn School of Medicine at Mount Sinai
Study Chair - Jose C. Clemente, PhD
Icahn Institute for Genomics & Multiscale Biology
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Mount Sinai West
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Nov 2018
- Primary completion
- 30 Jan 2025
- Completion
- 31 Jan 2027
- Last update posted
- 5 Nov 2025
- Registered enrollment
- 114
- Registry id
- NCT03567707
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.